Fundraising FoxVeloxis
1 known investors
Find your way into Veloxis
Sign up to see every warm intro you have to Veloxis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Veloxis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Veloxis Pharmaceuticals is a specialty pharmaceutical company that develops therapies and programs for the prevention of organ rejection in transplant patients, serving transplant healthcare providers and the patients they treat. It is part of Asahi Kasei Corporation and is advancing investigational immunosuppressive agents for kidney and heart transplant recipients.
Investors · 1
Frequently asked questions
- What does Veloxis do?
- Veloxis Pharmaceuticals is a specialty pharmaceutical company that develops therapies and programs for the prevention of organ rejection in transplant patients, serving transplant healthcare providers and the patients they treat. It is part of Asahi Kasei Corporation and is advancing investigational immunosuppressive agents for kidney and heart transplant recipients.
- Who are Veloxis's investors?
- Veloxis's investors include Rosetta Capital Ltd..